SYN
-
MA Beneficiaries With Cancer Spend Less on Healthcare Than Traditional Medicare Beneficiaries
Medicare Advantage beneficiaries with a cancer diagnosis spend $3,996 on out-of-pocket costs and premiums annually, versus $6,091 for traditional Medicare beneficiaries with cancer, a new report found.
-
Report: About Half of MA Beneficiaries Leave Their Plan After 5 Years
After five years of enrolling in a Medicare Advantage plan, 48.3% of non-dually enrolled beneficiaries left their contract and 53.4% of dually enrolled beneficiaries did, a new study found.
-
Payer’s Place: Don Antonucci
The CEO of Providence Health Plan visits the Payer’s Place and addresses the future of payment models.
-
Bicycle Health, Albertsons Form Partnership To Expand Access to OUD Treatment
Through a new partnership, Bicycle Health providers can prescribe patients buprenorphine extended release injections (otherwise known as Sublocade), which can be administered by a pharmacist at an Albertsons pharmacy.
-
Intermountain’s Value-based Subsidiary Selects Headspace for Mental Health Support
Through a new partnership, Castell will be able to refer members of its Utah health plan customers to Headspace for behavioral health coaching and therapy.
-
CMS Requires States To Assess Medicaid Disenrollment Process
Some states may not be following federal requirements for the Medicaid renewal process, resulting in many individuals being wrongly removed from coverage, CMS said. Children may especially be affected.
-
Strive Health, Oak Street Health Strike Kidney Care Partnership
Kidney care company Strive Health announced last week that it is collaborating with primary care company Oak Street Health to serve Medicare members with stage 4 chronic kidney disease and end-stage kidney disease.
-
Study On Teen Mental Health App Shows High Engagement, Positive Impact
A study on BeMe Health, a behavioral health platform for teens, found that users engaged with the platform eight times on average over a month. The study was done in collaboration with Stanford University.
-
HHS Drops First 10 Drugs for Medicare Drug Price Negotiation
HHS released the first 10 drugs selected for the Medicare Drug Price Negotiation Program. These drugs include Eliquis, Jardiance and Xarelto. Under the program, the federal government will be able to negotiate the price for selected drugs for the first time.
-
Payer’s Place: David Calabrese
OptumRx’s Chief Clinical Officer shares his insights on the latest developments and trends he’s seen in the healthcare industry.
-
Report: Many Employers, Consumers Don’t Understand Value-based Care
Although many employers and consumers don’t understand the difference between value-based care and fee-for-service, most are in favor of value-based care after being given the definition, a new survey found.
-
Report: MA Enrollees Use Postacute Services Less Than Traditional Medicare
A new study found that between 16.2% and 17.7% of Medicare Advantage enrollees reported using post-acute care services, compared to 22.4% to 24.1% of traditional Medicare enrollees.
-
CMS: Medicare Shared Savings Program Saved Medicare $1.8B in 2022
For the sixth year in a row, the Medicare Shared Savings Program created overall savings, CMS announced. When compared to clinician groups of a similar size not participating in the program, participating ACOs performed better on quality measures, including measures for diabetes, breast cancer and colorectal cancer screenings, tobacco screenings and depression screenings.
-
Humana Taps Interwell Health for Kidney Care
In a new agreement, Interwell Health will provide care to Humana Medicare Advantage HMO and PPO members with chronic kidney disease in 13 states. It will also serve patients with end-stage kidney disease across the country.
-
Employers’ Healthcare Costs Expected To Rise 8.5% in 2024
Employers’ healthcare costs are anticipated to rise by 8.5% in 2024, according to Aon. The projected increase is nearly twice the 4.5% increase that employers saw from 2022 to 2023. Inflation is a major factor for the increase.